The Vigabatrin REMS Program is called for by the FDA to make certain notified risk-benefit decisions prior to initiating treatment, and to ensure ideal use of vigabatrin while clients are treated. It is not feasible for your healthcare provider to understand when vision loss will certainly happen.
One of the most common adverse effects of SABRIL in children 3 to 16 years is weight gain. With extreme vision loss, you may only have the ability to see things straight in front of you (occasionally called one-track mind"). You are at danger for vision loss with any type of amount of SABRIL.
If you are pregnant or plan to obtain expecting, inform your healthcare supplier. If vision testing can not be done, your healthcare provider may continue suggesting SABRIL, but will not be able to look for any vision loss. Your medical care company may stop recommending SABRIL for you (or your child)if vision tests are not done routinely.